Truist Securities Starts Curis (CRIS) at Buy; 'The next Pharmacyclics'
Tweet Send to a Friend
(Updated - November 16, 2023 4:23 PM EST)
Truist Securities analyst Robyn Karnauskas initiates coverage on Curis (NASDAQ: CRIS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Robyn Karnauskas initiates coverage on Curis (NASDAQ: CRIS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
